查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530922

胃轻瘫治疗市场 - 全球产业分析、规模、份额、成长、趋势和预测，2024-2034 年

Gastroparesis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 153 Pages | 商品交期: 2-10个工作天内

价格

胃轻瘫治疗市场 - 报告范围

TMR 关于全球胃轻瘫治疗市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。 -2034年期间，考虑2024年为基准年，2034年为预测年。该报告也提供了2024年至2034年全球胃轻瘫治疗市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。次要研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解胃轻瘫治疗市场。

市场概况
2023年市场价值 63 亿美元
2034 年市场价值 103 亿美元
复合年增长率 4.6%

该报告深入探讨了全球胃轻瘫治疗市场的竞争格局。全球胃轻瘫治疗市场的主要参与者已经确定，并且每位参与者都根据各种属性进行了分析。公司概况、财务状况、近期发展和 SWOT 是本报告中介绍的全球胃轻瘫治疗市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依药物类别

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依药品类别，2020-2034
    • 促动力剂
    • 止吐药
    • 质子帮浦抑制剂
    • 其他（肉毒桿菌注射等）
  • 市场吸引力：按药品类别

第 7 章：全球市场分析与预测：按疾病适应症

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依疾病适应症，2020-2034
    • 糖尿病胃轻瘫
    • 特发性胃轻瘫
    • 术后胃轻瘫
  • 市场吸引力：依疾病适应症分类

第 8 章：全球市场分析与预测：按类型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按类型，2020-2034
    • 非处方药
    • 处方药
  • 市场吸引力：按类型

第 9 章：全球市场分析与预测：按给药途径

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依给药途径，2020-2034年
    • 口服
    • 注射剂
    • 鼻腔
  • 市场吸引力：依给药途径分类

第 10 章：全球市场分析与预测：按配销通路

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按配销通路，2020-2034
    • 医院药房
    • 零售药局
    • 网路药局
  • 市场吸引力：按配销通路划分

第 11 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020-2034
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 12 章：北美市场分析与预测

第 13 章：欧洲市场分析与预测

第 14 章：亚太市场分析与预测

第 15 章：拉丁美洲市场分析与预测

第 16 章：中东和非洲市场分析与预测

第17章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司分类（2023）
  • 公司简介
    • Abbott Laboratories
    • AbbVie Inc.
    • AstraZeneca plc
    • Bayer AG
    • Cipla Limited
    • Evoke Pharma
    • Pfizer Inc.
    • Salix Pharmaceuticals, Inc.
    • The Takeda Pharmaceutical Company Limited
    • Teva Pharmaceutical Industries Ltd.
Product Code: TMRGL39305

Gastroparesis Treatment Market - Scope of Report

TMR's report on the global gastroparesis treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global gastroparesis treatment market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global gastroparesis treatment market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the gastroparesis treatment market.

Market Snapshot
Market Value in 2023US$ 6.3 Bn
Market Value in 2034US$ 10.3 Bn
CAGR4.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global gastroparesis treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global gastroparesis treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global gastroparesis treatment market.

The report delves into the competitive landscape of the global gastroparesis treatment market. Key players operating in the global gastroparesis treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global gastroparesis treatment market profiled in this report.

Key Questions Answered in Global gastroparesis treatment Market Report:

  • What is the sales/revenue generated by gastroparesis treatment across all regions during the forecast period?
  • What are the opportunities in the global gastroparesis treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Gastroparesis Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global gastroparesis treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global gastroparesis treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global gastroparesis treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Gastroparesis Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Gastroparesis Treatment Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Gastroparesis Treatment Market Analysis and Forecast, by Drug Class

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Drug Class, 2020-2034
    • 6.3.1. Prokinetic Agents
    • 6.3.2. Antiemetic Drugs
    • 6.3.3. Proton Pump Inhibitors
    • 6.3.4. Others (Botulinum Toxin Injections, etc.)
  • 6.4. Market Attractiveness, by Drug Class

7. Global Gastroparesis Treatment Market Analysis and Forecast, by Disease Indication

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Disease Indication, 2020-2034
    • 7.3.1. Diabetes Gastroparesis
    • 7.3.2. Idiopathic Gastroparesis
    • 7.3.3. Post-surgical Gastroparesis
  • 7.4. Market Attractiveness, by Disease Indication

8. Global Gastroparesis Treatment Market Analysis and Forecast, By Type

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, By Type, 2020-2034
    • 8.3.1. Over-the-Counter Drugs
    • 8.3.2. Prescription Drugs
  • 8.4. Market Attractiveness, By Type

9. Global Gastroparesis Treatment Market Analysis and Forecast, by Route of Administration

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Route of Administration, 2020-2034
    • 9.3.1. Oral
    • 9.3.2. Injectables
    • 9.3.3. Nasal
  • 9.4. Market Attractiveness, by Route of Administration

10. Global Gastroparesis Treatment Market Analysis and Forecast, by Distribution Channel

  • 10.1. Introduction and Definitions
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by Distribution Channel, 2020-2034
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
  • 10.4. Market Attractiveness, by Distribution Channel

11. Global Gastroparesis Treatment Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2020-2034
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness, by Region

12. North America Gastroparesis Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Drug Class, 2020-2034
    • 12.2.1. Prokinetic Agents
    • 12.2.2. Antiemetic Drugs
    • 12.2.3. Proton Pump Inhibitors
    • 12.2.4. Others (Botulinum Toxin Injections, etc.)
  • 12.3. Market Attractiveness, by Drug Class
  • 12.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 12.4.1. Diabetes Gastroparesis
    • 12.4.2. Idiopathic Gastroparesis
    • 12.4.3. Post-surgical Gastroparesis
  • 12.5. Market Attractiveness, by Disease Indication
  • 12.6. Market Value Forecast, By Type, 2020-2034
    • 12.6.1. Over-the-Counter Drugs
    • 12.6.2. Prescription Drugs
  • 12.7. Market Attractiveness, By Type
  • 12.8. Market Value Forecast, by Route of Administration, 2020-2034
    • 12.8.1. Oral
    • 12.8.2. Injectables
    • 12.8.3. Nasal
  • 12.9. Market Attractiveness, by Route of Administration
  • 12.10. Market Value Forecast, by Distribution Channel, 2020-2034
    • 12.10.1. Hospital Pharmacies
    • 12.10.2. Retail Pharmacies
    • 12.10.3. Online Pharmacies
  • 12.11. Market Attractiveness, by Distribution Channel
  • 12.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.12.1. U.S.
    • 12.12.2. Canada
  • 12.13. Market Attractiveness Analysis
    • 12.13.1. By Drug Class
    • 12.13.2. By Disease Indication
    • 12.13.3. By Type
    • 12.13.4. By Route of Administration
    • 12.13.5. By Distribution Channel
    • 12.13.6. By Country

13. Europe Gastroparesis Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Drug Class, 2020-2034
    • 13.2.1. Prokinetic Agents
    • 13.2.2. Antiemetic Drugs
    • 13.2.3. Proton Pump Inhibitors
    • 13.2.4. Others (Botulinum Toxin Injections, etc.)
  • 13.3. Market Attractiveness, by Drug Class
  • 13.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 13.4.1. Diabetes Gastroparesis
    • 13.4.2. Idiopathic Gastroparesis
    • 13.4.3. Post-surgical Gastroparesis
  • 13.5. Market Attractiveness, by Disease Indication
  • 13.6. Market Value Forecast, By Type, 2020-2034
    • 13.6.1. Over-the-Counter Drugs
    • 13.6.2. Prescription Drugs
  • 13.7. Market Attractiveness, By Type
  • 13.8. Market Value Forecast, by Route of Administration, 2020-2034
    • 13.8.1. Oral
    • 13.8.2. Injectables
    • 13.8.3. Nasal
  • 13.9. Market Attractiveness, by Route of Administration
  • 13.10. Market Value Forecast, by Distribution Channel, 2020-2034
    • 13.10.1. Hospital Pharmacies
    • 13.10.2. Retail Pharmacies
    • 13.10.3. Online Pharmacies
  • 13.11. Market Attractiveness, by Distribution Channel
  • 13.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.12.1. Germany
    • 13.12.2. U.K.
    • 13.12.3. France
    • 13.12.4. Italy
    • 13.12.5. Spain
    • 13.12.6. Rest of Europe
  • 13.13. Market Attractiveness Analysis
    • 13.13.1. By Drug Class
    • 13.13.2. By Disease Indication
    • 13.13.3. By Type
    • 13.13.4. By Route of Administration
    • 13.13.5. By Distribution Channel
    • 13.13.6. By Country/Sub-region

14. Asia Pacific Gastroparesis Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Drug Class, 2020-2034
    • 14.2.1. Prokinetic Agents
    • 14.2.2. Antiemetic Drugs
    • 14.2.3. Proton Pump Inhibitors
    • 14.2.4. Others (Botulinum Toxin Injections, etc.)
  • 14.3. Market Attractiveness, by Drug Class
  • 14.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 14.4.1. Diabetes Gastroparesis
    • 14.4.2. Idiopathic Gastroparesis
    • 14.4.3. Post-surgical Gastroparesis
  • 14.5. Market Attractiveness, by Disease Indication
  • 14.6. Market Value Forecast, By Type, 2020-2034
    • 14.6.1. Over-the-Counter Drugs
    • 14.6.2. Prescription Drugs
  • 14.7. Market Attractiveness, By Type
  • 14.8. Market Value Forecast, by Route of Administration, 2020-2034
    • 14.8.1. Oral
    • 14.8.2. Injectables
    • 14.8.3. Nasal
  • 14.9. Market Attractiveness, by Route of Administration
  • 14.10. Market Value Forecast, by Distribution Channel, 2020-2034
    • 14.10.1. Hospital Pharmacies
    • 14.10.2. Retail Pharmacies
    • 14.10.3. Online Pharmacies
  • 14.11. Market Attractiveness, by Distribution Channel
  • 14.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.12.1. China
    • 14.12.2. Japan
    • 14.12.3. India
    • 14.12.4. Australia & New Zealand
    • 14.12.5. Rest of Asia Pacific
  • 14.13. Market Attractiveness Analysis
    • 14.13.1. By Drug Class
    • 14.13.2. By Disease Indication
    • 14.13.3. By Type
    • 14.13.4. By Route of Administration
    • 14.13.5. By Distribution Channel
    • 14.13.6. By Country/Sub-region

15. Latin America Gastroparesis Treatment Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Drug Class, 2020-2034
    • 15.2.1. Prokinetic Agents
    • 15.2.2. Antiemetic Drugs
    • 15.2.3. Proton Pump Inhibitors
    • 15.2.4. Others (Botulinum Toxin Injections, etc.)
  • 15.3. Market Attractiveness, by Drug Class
  • 15.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 15.4.1. Diabetes Gastroparesis
    • 15.4.2. Idiopathic Gastroparesis
    • 15.4.3. Post-surgical Gastroparesis
  • 15.5. Market Attractiveness, by Disease Indication
  • 15.6. Market Value Forecast, By Type, 2020-2034
    • 15.6.1. Over-the-Counter Drugs
    • 15.6.2. Prescription Drugs
  • 15.7. Market Attractiveness, By Type
  • 15.8. Market Value Forecast, by Route of Administration, 2020-2034
    • 15.8.1. Oral
    • 15.8.2. Injectables
    • 15.8.3. Nasal
  • 15.9. Market Attractiveness, by Route of Administration
  • 15.10. Market Value Forecast, by Distribution Channel, 2020-2034
    • 15.10.1. Hospital Pharmacies
    • 15.10.2. Retail Pharmacies
    • 15.10.3. Online Pharmacies
  • 15.11. Market Attractiveness, by Distribution Channel
  • 15.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.12.1. Brazil
    • 15.12.2. Mexico
    • 15.12.3. Rest of Latin America
  • 15.13. Market Attractiveness Analysis
    • 15.13.1. By Drug Class
    • 15.13.2. By Disease Indication
    • 15.13.3. By Type
    • 15.13.4. By Route of Administration
    • 15.13.5. By Distribution Channel
    • 15.13.6. By Country/Sub-region

16. Middle East & Africa Gastroparesis Treatment Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Drug Class, 2020-2034
    • 16.2.1. Prokinetic Agents
    • 16.2.2. Antiemetic Drugs
    • 16.2.3. Proton Pump Inhibitors
    • 16.2.4. Others (Botulinum Toxin Injections, etc.)
  • 16.3. Market Attractiveness, by Drug Class
  • 16.4. Market Value Forecast, by Disease Indication, 2020-2034
    • 16.4.1. Diabetes Gastroparesis
    • 16.4.2. Idiopathic Gastroparesis
    • 16.4.3. Post-surgical Gastroparesis
  • 16.5. Market Attractiveness, by Disease Indication
  • 16.6. Market Value Forecast, By Type, 2020-2034
    • 16.6.1. Over-the-Counter Drugs
    • 16.6.2. Prescription Drugs
  • 16.7. Market Attractiveness, By Type
  • 16.8. Market Value Forecast, by Route of Administration, 2020-2034
    • 16.8.1. Oral
    • 16.8.2. Injectables
    • 16.8.3. Nasal
  • 16.9. Market Attractiveness, by Route of Administration
  • 16.10. Market Value Forecast, by Distribution Channel, 2020-2034
    • 16.10.1. Hospital Pharmacies
    • 16.10.2. Retail Pharmacies
    • 16.10.3. Online Pharmacies
  • 16.11. Market Attractiveness, by Distribution Channel
  • 16.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 16.12.1. GCC Countries
    • 16.12.2. South Africa
    • 16.12.3. Rest of Middle East & Africa
  • 16.13. Market Attractiveness Analysis
    • 16.13.1. By Drug Class
    • 16.13.2. By Disease Indication
    • 16.13.3. By Type
    • 16.13.4. By Route of Administration
    • 16.13.5. By Distribution Channel
    • 16.13.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2023)
  • 17.3. Company Profiles
    • 17.3.1. Abbott Laboratories
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. SWOT Analysis
      • 17.3.1.5. Strategic Overview
    • 17.3.2. AbbVie Inc.
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. SWOT Analysis
      • 17.3.2.5. Strategic Overview
    • 17.3.3. AstraZeneca plc
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. SWOT Analysis
      • 17.3.3.5. Strategic Overview
    • 17.3.4. Bayer AG
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
      • 17.3.4.5. Strategic Overview
    • 17.3.5. Cipla Limited
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. SWOT Analysis
      • 17.3.5.5. Strategic Overview
    • 17.3.6. Evoke Pharma
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. SWOT Analysis
      • 17.3.6.5. Strategic Overview
    • 17.3.7. Pfizer Inc.
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. SWOT Analysis
      • 17.3.7.5. Strategic Overview
    • 17.3.8. Salix Pharmaceuticals, Inc.
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. Financial Overview
      • 17.3.8.4. SWOT Analysis
      • 17.3.8.5. Strategic Overview
    • 17.3.9. The Takeda Pharmaceutical Company Limited
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. SWOT Analysis
      • 17.3.9.5. Strategic Overview
    • 17.3.10. Teva Pharmaceutical Industries Ltd.
      • 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.10.2. Product Portfolio
      • 17.3.10.3. Financial Overview
      • 17.3.10.4. SWOT Analysis
      • 17.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 02: Global Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 03: Global Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 04: Global Gastroparesis Treatment Market Size (US$ Bn) Forecast, By Type, 2020-2034
  • Table 05: Global Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 06: Global Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 07: North America Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 08: North America Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 09: North America Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 10: North America Gastroparesis Treatment Market Size (US$ Bn) Forecast, By Type, 2020-2034
  • Table 11: North America Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 12: North America Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 13: Europe Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Europe Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 15: Europe Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 16: Europe Gastroparesis Treatment Market Size (US$ Bn) Forecast, By Type, 2020-2034
  • Table 17: Europe Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 18: Europe Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 19: Asia Pacific Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 20: Asia Pacific Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 21: Asia Pacific Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 22: Asia Pacific Gastroparesis Treatment Market Size (US$ Bn) Forecast, By Type, 2020-2034
  • Table 23: Asia Pacific Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 24: Asia Pacific Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 25: Latin America Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 26: Latin America Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 27: Latin America Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 28: Latin America Gastroparesis Treatment Market Size (US$ Bn) Forecast, By Type, 2020-2034
  • Table 29: Latin America Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 30: Latin America Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 31: Middle East & Africa Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 32: Middle East & Africa Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034
  • Table 33: Middle East & Africa Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 34: Middle East & Africa Gastroparesis Treatment Market Size (US$ Bn) Forecast, By Type, 2020-2034
  • Table 35: Middle East & Africa Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 36: Middle East & Africa Gastroparesis Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Global Gastroparesis Treatment Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Global Gastroparesis Treatment Market Revenue (US$ Bn), by Drug Class, 2023
  • Figure 03: Global Gastroparesis Treatment Market Value Share, by Drug Class, 2023
  • Figure 04: Global Gastroparesis Treatment Market Revenue (US$ Bn), by Disease Indication, 2023
  • Figure 05: Global Gastroparesis Treatment Market Value Share, by Disease Indication, 2023
  • Figure 06: Global Gastroparesis Treatment Market Revenue (US$ Bn), By Type, 2023
  • Figure 07: Global Gastroparesis Treatment Market Value Share, By Type, 2023
  • Figure 08: Global Gastroparesis Treatment Market Revenue (US$ Bn), by Route of Administration, 2023
  • Figure 09: Global Gastroparesis Treatment Market Value Share, by Route of Administration, 2023
  • Figure 10: Global Gastroparesis Treatment Market Revenue (US$ Bn), by Distribution Channel, 2023
  • Figure 11: Global Gastroparesis Treatment Market Value Share, by Distribution Channel, 2023
  • Figure 12: Global Gastroparesis Treatment Market Value Share, by Region, 2023
  • Figure 13: Global Gastroparesis Treatment Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 14: Global Gastroparesis Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 15: Global Gastroparesis Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 16: Global Gastroparesis Treatment Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 17: Global Gastroparesis Treatment Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 18: Global Gastroparesis Treatment Market Value Share Analysis, By Type, 2023 and 2034
  • Figure 19: Global Gastroparesis Treatment Market Attractiveness Analysis, By Type, 2024-2034
  • Figure 20: Global Gastroparesis Treatment Market Revenue (US$ Bn), by Route of Administration, 2023
  • Figure 21: Global Gastroparesis Treatment Market Value Share, by Route of Administration, 2023
  • Figure 22: Global Gastroparesis Treatment Market Revenue (US$ Bn), by Distribution Channel, 2023
  • Figure 23: Global Gastroparesis Treatment Market Value Share, by Distribution Channel, 2023
  • Figure 24: Global Gastroparesis Treatment Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 25: Global Gastroparesis Treatment Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 26: North America Gastroparesis Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 27: North America Gastroparesis Treatment Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 28: North America Gastroparesis Treatment Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 29: North America Gastroparesis Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 30: North America Gastroparesis Treatment Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 31: North America Gastroparesis Treatment Market Value Share Analysis, By Type, 2023 and 2034
  • Figure 32: North America Gastroparesis Treatment Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 33: North America Gastroparesis Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 34: North America Gastroparesis Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 35: North America Gastroparesis Treatment Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 36: North America Gastroparesis Treatment Market Attractiveness Analysis, By Type, 2023-2034
  • Figure 37: North America Gastroparesis Treatment Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 38: North America Gastroparesis Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 39: Europe Gastroparesis Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 40: Europe Gastroparesis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 41: Europe Gastroparesis Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 42: Europe Gastroparesis Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 43: Europe Gastroparesis Treatment Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 44: Europe Gastroparesis Treatment Market Value Share Analysis, By Type, 2023 and 2034
  • Figure 45: Europe Gastroparesis Treatment Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 46: Europe Gastroparesis Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 47: Europe Gastroparesis Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 48: Europe Gastroparesis Treatment Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 49: Europe Gastroparesis Treatment Market Attractiveness Analysis, By Type, 2024-2034
  • Figure 50: Europe Gastroparesis Treatment Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 51: Europe Gastroparesis Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 52: Asia Pacific Gastroparesis Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 53: Asia Pacific Gastroparesis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 54: Asia Pacific Gastroparesis Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 55: Asia Pacific Gastroparesis Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 56: Asia Pacific Gastroparesis Treatment Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 57: Asia Pacific Gastroparesis Treatment Market Value Share Analysis, By Type, 2023 and 2034
  • Figure 58: Asia Pacific Gastroparesis Treatment Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 59: Asia Pacific Gastroparesis Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 60: Asia Pacific Gastroparesis Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 61: Asia Pacific Gastroparesis Treatment Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 62: Asia Pacific Gastroparesis Treatment Market Attractiveness Analysis, By Type, 2024-2034
  • Figure 63: Asia Pacific Gastroparesis Treatment Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 64: Asia Pacific Gastroparesis Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 65: Latin America Gastroparesis Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 66: Latin America Gastroparesis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 67: Latin America Gastroparesis Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 68: Latin America Gastroparesis Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 69: Latin America Gastroparesis Treatment Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 70: Latin America Gastroparesis Treatment Market Value Share Analysis, By Type, 2023 and 2034
  • Figure 71: Latin America Gastroparesis Treatment Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 72: Latin America Gastroparesis Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 73: Latin America Gastroparesis Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 74: Latin America Gastroparesis Treatment Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 75: Latin America Gastroparesis Treatment Market Attractiveness Analysis, By Type, 2023-2034
  • Figure 76: Latin America Gastroparesis Treatment Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 77: Latin America Gastroparesis Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 78: Middle East & Africa Gastroparesis Treatment Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 79: Middle East & Africa Gastroparesis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 80: Middle East & Africa Gastroparesis Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 81: Middle East & Africa Gastroparesis Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 82: Middle East & Africa Gastroparesis Treatment Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 83: Middle East & Africa Gastroparesis Treatment Market Value Share Analysis, By Type, 2023 and 2034
  • Figure 84: Middle East & Africa Gastroparesis Treatment Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 85: Middle East & Africa Gastroparesis Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 86: Middle East & Africa Gastroparesis Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034
  • Figure 87: Middle East & Africa Gastroparesis Treatment Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 88: Middle East & Africa Gastroparesis Treatment Market Attractiveness Analysis, By Type, 2023-2034
  • Figure 89: Middle East & Africa Gastroparesis Treatment Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 90: Middle East & Africa Gastroparesis Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034